Achieve Life Sciences, Inc. (ACHV)
NASDAQ: ACHV · Real-Time Price · USD
4.270
+0.310 (7.83%)
At close: Apr 28, 2026, 4:00 PM EDT
4.280
+0.010 (0.23%)
After-hours: Apr 28, 2026, 4:24 PM EDT
Achieve Life Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 31.88 | 16.25 | 11.44 | 10.72 | 9.13 | |
| Research & Development | 23 | 22.82 | 15.81 | 30.08 | 23.97 | |
| Operating Expenses | 54.88 | 39.07 | 27.25 | 40.8 | 33.09 | |
| Operating Income | -54.88 | -39.07 | -27.25 | -40.8 | -33.09 | |
| Interest Expense | -0.82 | -2.18 | -2.85 | -1.79 | - | |
| Interest & Investment Income | 1.5 | 2.36 | 0.83 | 0.2 | 0.02 | |
| Other Non Operating Income (Expenses) | -0.04 | -0.03 | -0.01 | 0.04 | -0.08 | |
| EBT Excluding Unusual Items | -54.24 | -38.92 | -29.29 | -42.35 | -33.15 | |
| Other Unusual Items | -0.41 | -0.9 | -0.53 | - | - | |
| Pretax Income | -54.65 | -39.83 | -29.82 | -42.35 | -33.15 | |
| Net Income | -54.65 | -39.83 | -29.82 | -42.35 | -33.15 | |
| Net Income to Common | -54.65 | -39.83 | -29.82 | -42.35 | -33.15 | |
| Shares Outstanding (Basic) | 44 | 32 | 20 | 11 | 8 | |
| Shares Outstanding (Diluted) | 44 | 32 | 20 | 11 | 8 | |
| Shares Change (YoY) | 35.93% | 61.75% | 87.17% | 30.46% | 198.64% | |
| EPS (Basic) | -1.25 | -1.24 | -1.50 | -4.00 | -4.08 | |
| EPS (Diluted) | -1.25 | -1.24 | -1.50 | -4.00 | -4.08 | |
| Free Cash Flow | -49.47 | -29.77 | -24.5 | -37.57 | -29.44 | |
| Free Cash Flow Per Share | -1.14 | -0.93 | -1.24 | -3.55 | -3.63 | |
| EBITDA | -54.65 | -38.84 | -27.02 | -40.56 | -32.84 | |
| D&A For EBITDA | 0.23 | 0.23 | 0.23 | 0.24 | 0.25 | |
| EBIT | -54.88 | -39.07 | -27.25 | -40.8 | -33.09 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.